BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Veralox Therapeutics

Veralox Therapeutics logo

Founded
2017
Geography
United States of America based
Funding
$5.400 M

Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.

Technologies

AI Companies (Drug Discovery)  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet